Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.

Adeel Ajwad ButtVictor B TalisaPeng YanObaid S ShaikhSaad B OmerFlorian B Mayr

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

VE of 2 doses of current mRNA vaccines in preventing SARS-CoV-2 infection in persons on chronic hemodialysis is lower than historic VE rates in the general population. Effects of additional doses in improving VE in this special population need further study.

Keyphrases

respiratory syndrome coronavirus
sars cov
end stage renal disease
chronic kidney disease
peritoneal dialysis
coronavirus disease
ejection fraction
newly diagnosed
randomized controlled trial
systematic review
prognostic factors
binding protein
patient reported outcomes
drug induced